Preclinical models for drug selection in myeloproliferative neoplasms. [electronic resource]
- Current hematologic malignancy reports Dec 2013
- 317-24 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1558-822X
10.1007/s11899-013-0182-1 doi
Animals Antineoplastic Agents--therapeutic use Disease Models, Animal Drug Evaluation, Preclinical GATA1 Transcription Factor--physiology Gene Knock-In Techniques Hematologic Neoplasms--drug therapy Humans Janus Kinase 2--antagonists & inhibitors Mice Mice, Transgenic Molecular Targeted Therapy--methods Myeloproliferative Disorders--drug therapy Protein Kinase Inhibitors--therapeutic use